NasdaqCM - Delayed Quote USD
Alterity Therapeutics Limited (ATHE)
3.5100
+0.0400
+(1.15%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-12,605.8240
--
--
--
--
Operating Cash Flow
-12,605.8240
-12,605.8240
-20,035.8370
-12,337.2740
-17,330.0690
Investing Cash Flow
-5.7220
-5.7220
-36.4610
-89.1470
-10.4720
Financing Cash Flow
9,216.2920
9,216.2920
124.3400
16,304.5580
36,685.9470
End Cash Position
12,638.8850
12,638.8850
15,773.7830
34,806.7990
28,115.5160
Capital Expenditure
-5.7220
-5.7220
-7.3110
-89.1470
-10.4720
Issuance of Capital Stock
10,144.6820
10,144.6820
316.6750
17,176.0400
39,236.8860
Issuance of Debt
50
--
--
--
--
Repayment of Debt
-10.3700
-10.3700
-59.9220
-34.5130
-58.2890
Free Cash Flow
-12,611.5460
-12,611.5460
-20,043.1480
-12,426.4210
-17,340.5410
6/30/2021 - 9/29/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IUGNF Imugene Limited
0.0200
0.00%
NLSP NLS Pharmaceutics AG
1.4700
+2.80%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%
EQ Equillium, Inc.
0.4800
+1.69%
SPRC SciSparc Ltd.
0.2869
+4.48%
DBVT DBV Technologies S.A.
9.26
+5.83%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
+15.04%
IMRN Immuron Limited
1.7178
-2.95%
ENTO Entero Therapeutics, Inc.
0.3619
-3.24%
LPCN Lipocine Inc.
3.1000
+2.99%